Neumora Therapeutics, Inc. Common Stock (NMRA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q4'20 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 8K | 0 | 5M | 0 | 0 | 0 | 0 | 0 | 0 | 166K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -8K | 0 | -5M | 0 | 0 | 0 | 0 | 0 | 0 | -166K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 52.86M | 58.48M | 52.7M | 54.04M | 70.94M | 62.92M | 76.65M | 63.82M | 60.07M | 49.93M | 56.86M | 42.06M | 39.17M | 30.72M | 31.31M | 43.24M | 26.55M | 178.13M | 19.53M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 14.27M | 13.81M | 12.18M | 15.32M | 18.79M | 17.01M | 16.02M | 15.19M | 14.32M | 11.07M | 15.26M | 9.29M | 9.68M | 7.2M | 7.79M | 8.09M | 7.64M | 6.66M | 4.29M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 38.6M | 44.67M | 40.52M | 38.72M | 52.15M | 45.91M | 60.63M | 48.63M | 45.76M | 38.86M | 41.6M | 32.77M | 29.48M | 23.52M | 23.53M | 35.15M | 18.91M | 171.47M | 15.23M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -52.86M | -58.48M | -57.7M | -54.04M | -70.94M | -62.92M | -76.65M | -63.82M | -60.07M | -50.1M | -56.86M | -42.06M | -39.17M | -30.72M | -31.31M | -43.24M | -26.55M | -178.13M | -19.53M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 25.48% | 7.06% | 24.72% | 15.33% | -18.08% | -25.59% | -34.79% | -51.73% | -53.38% | -63.1% | - | -34.32% | 9.41% | -15.71% | - | - | -35.94% | - | - |
| EBITDA | -52.86M | -58.47M | -57.68M | -54.02M | -70.78M | -62.77M | -76.49M | -63.66M | -59.92M | -49.93M | -56.69M | -41.89M | -39.01M | -30.57M | -31.16M | -43.09M | -26.42M | -177.98M | -19.46M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 25.32% | 6.84% | 24.6% | 15.14% | -18.13% | -25.7% | -34.92% | -51.97% | -53.59% | -63.34% | - | -34.44% | 9.47% | -15.73% | - | - | -35.71% | - | - |
| D&A (Non-Cash Add-back) | 8K | 9K | 23K | 19K | 157K | 157K | 156K | 160K | 158K | 166K | 173K | 171K | 158K | 147K | 154K | 147K | 131K | 150K | 63K |
| EBIT | -52.86M | -57.41M | -56.01M | -54.04M | -70.94M | -62.92M | -76.65M | -63.82M | -60.07M | -108.46M | -56.86M | -42.06M | -39.17M | -30.72M | -31.31M | -43.24M | -26.55M | -178.13M | -19.53M |
| Net Interest Income | -623K | -701K | 938K | 1.81M | 3.07M | 4.09M | 4.21M | 5.27M | 6.37M | 5.65M | 3.84M | 3.56M | 3.57M | 2.29M | 784K | 86K | 0 | 0 | 0 |
| Interest Income | 1.23M | 1.33M | 1.69M | 1.81M | 3.07M | 4.09M | 4.21M | 5.27M | 6.37M | 5.65M | 3.84M | 3.56M | 3.57M | 2.29M | 784K | 86K | 0 | 0 | 0 |
| Interest Expense | 1.85M | 2.04M | 747K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -564K | -970K | 945K | 1.33M | 3.05M | 4.1M | 4.15M | 5.25M | 6.35M | -58.36M | 3.84M | 3.52M | 3.54M | 2.57M | 942K | 194K | -422K | 103K | -470K |
| Pretax Income | -53.43M | -59.45M | -56.76M | -52.71M | -67.89M | -58.82M | -72.49M | -58.58M | -53.72M | -108.46M | -53.03M | -38.54M | -35.63M | -28.15M | -30.37M | -43.04M | -26.97M | -178.03M | -20M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 30K | 0 | 0 | 25K | 105K | 0 | 53K | 125K | 0 | 268K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.06% | 0% | 0% | -0.05% | -0.15% | 0% | -0.07% | -0.21% | 0% | -0.25% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -53.46M | -59.45M | -56.76M | -52.73M | -67.99M | -58.82M | -72.55M | -58.7M | -53.72M | -108.73M | -53.03M | -38.54M | -35.63M | -28.15M | -30.37M | -43.04M | -26.97M | -178.03M | -20M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 21.38% | -1.07% | 21.77% | 10.17% | -26.57% | 45.9% | -36.81% | -52.3% | -50.8% | -286.31% | - | -26.9% | 17.23% | -4.36% | - | - | -34.86% | - | - |
| Net Income (Continuing) | -53.46M | -59.45M | -56.76M | -52.73M | -67.99M | -58.82M | -72.55M | -58.7M | -53.72M | -108.73M | -53.03M | -38.54M | -35.63M | -28.15M | -30.37M | -43.04M | -26.97M | -178.03M | -20M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.30 | -0.35 | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | -0.68 | -0.34 | -0.25 | -0.23 | -0.19 | -0.20 | -0.28 | -0.18 | -1.17 | -0.13 |
| EPS Growth % | 28.57% | 5.41% | 22.22% | 10.81% | -23.53% | 45.59% | -32.35% | -48% | -47.83% | -257.89% | - | -25% | 17.86% | -5.56% | - | - | -38.46% | - | - |
| EPS (Basic) | -0.30 | -0.35 | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 | -0.68 | -0.34 | -0.25 | -0.23 | -0.19 | -0.20 | -0.28 | -0.18 | -1.17 | -0.13 |
| Diluted Shares Outstanding | 179.87M | 163.39M | 161.84M | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | 158.83M | 155.39M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M |
| Basic Shares Outstanding | 179.87M | 163.39M | 161.84M | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | 158.83M | 155.39M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M | 151.95M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |